High‐throughput transcriptomic profiling of mRNAs and lncRNAs in the dermatomyositis muscle by RNA sequencing

Abstract Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy (IIM). In this study, we investigated the mRNAs and long noncoding RNAs (lncRNAs) in muscle biopsy specimens that are differentially expressed among patients with DM, patients with other IIM, and healthy controls (HCs)....

Full description

Bibliographic Details
Main Authors: Ke Li, Yubao Ma, Shanchun Zhang, Rui Ban, Qiang Shi
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Rheumatology & Autoimmunity
Subjects:
Online Access:https://doi.org/10.1002/rai2.12078
_version_ 1797672447094292480
author Ke Li
Yubao Ma
Shanchun Zhang
Rui Ban
Qiang Shi
author_facet Ke Li
Yubao Ma
Shanchun Zhang
Rui Ban
Qiang Shi
author_sort Ke Li
collection DOAJ
description Abstract Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy (IIM). In this study, we investigated the mRNAs and long noncoding RNAs (lncRNAs) in muscle biopsy specimens that are differentially expressed among patients with DM, patients with other IIM, and healthy controls (HCs). Methods In total, three patients with DM, 10 patients with other IIM, and three HCs were included. Muscle biopsy specimens were collected for RNA‐sequencing. Gene ontology and pathway analyses were employed to characterize the biological processes and signaling pathways. Results Compared with HCs, 372 differentially expressed mRNAs were identified within the DM group, including 275 upregulated and 97 downregulated ones. Moreover, 692 differentially expressed lncRNAs were identified in the DM group compared with HCs, of which 407 were upregulated and 285 were downregulated. Bioinformatic analysis indicated that the type‐I interferon signaling pathway and biological processes of innate immunity were significantly influenced by the differentially expressed mRNAs. Notably, 11 of the top 20 upregulated mRNAs were involved in the type‐I interferon signaling pathway. Reverse transcription polymerase chain reaction analysis verified the RNA‐sequencing data. Target gene prediction analysis suggested that the lncRNA NONHSAG043573.2 potentially targeting transporter associated with antigen processing 1, a key regulator of interferon signaling genes, might play an important role in the pathogenesis of DM. Conclusions Our study assessed the transcriptomic profiles of differentially expressed mRNAs and lncRNAs in the DM muscle tissue and revealed that the upregulated mRNAs are significantly involved in the innate immune response and the type‐I interferon signaling pathway, which might play important roles in the pathogenesis of DM.
first_indexed 2024-03-11T21:30:11Z
format Article
id doaj.art-bf805dcba49040f9bf6f2200b9992c9e
institution Directory Open Access Journal
issn 2767-1429
language English
last_indexed 2024-03-11T21:30:11Z
publishDate 2023-09-01
publisher Wiley
record_format Article
series Rheumatology & Autoimmunity
spelling doaj.art-bf805dcba49040f9bf6f2200b9992c9e2023-09-27T10:22:43ZengWileyRheumatology & Autoimmunity2767-14292023-09-013316617810.1002/rai2.12078High‐throughput transcriptomic profiling of mRNAs and lncRNAs in the dermatomyositis muscle by RNA sequencingKe Li0Yubao Ma1Shanchun Zhang2Rui Ban3Qiang Shi4Department of Neurology, The Second Medical Center Chinese PLA General Hospital Beijing ChinaDepartment of Neurology, The First Medical Center Chinese PLA General Hospital Beijing ChinaDepartment of Neurology, The Second Medical Center Chinese PLA General Hospital Beijing ChinaDepartment of Neurology The First Affiliated Hospital of Tsinghua University Beijing ChinaDepartment of National Clinical Research Center of Geriatrics Disease Chinese PLA General Hospital Beijing ChinaAbstract Background Dermatomyositis (DM) is an idiopathic inflammatory myopathy (IIM). In this study, we investigated the mRNAs and long noncoding RNAs (lncRNAs) in muscle biopsy specimens that are differentially expressed among patients with DM, patients with other IIM, and healthy controls (HCs). Methods In total, three patients with DM, 10 patients with other IIM, and three HCs were included. Muscle biopsy specimens were collected for RNA‐sequencing. Gene ontology and pathway analyses were employed to characterize the biological processes and signaling pathways. Results Compared with HCs, 372 differentially expressed mRNAs were identified within the DM group, including 275 upregulated and 97 downregulated ones. Moreover, 692 differentially expressed lncRNAs were identified in the DM group compared with HCs, of which 407 were upregulated and 285 were downregulated. Bioinformatic analysis indicated that the type‐I interferon signaling pathway and biological processes of innate immunity were significantly influenced by the differentially expressed mRNAs. Notably, 11 of the top 20 upregulated mRNAs were involved in the type‐I interferon signaling pathway. Reverse transcription polymerase chain reaction analysis verified the RNA‐sequencing data. Target gene prediction analysis suggested that the lncRNA NONHSAG043573.2 potentially targeting transporter associated with antigen processing 1, a key regulator of interferon signaling genes, might play an important role in the pathogenesis of DM. Conclusions Our study assessed the transcriptomic profiles of differentially expressed mRNAs and lncRNAs in the DM muscle tissue and revealed that the upregulated mRNAs are significantly involved in the innate immune response and the type‐I interferon signaling pathway, which might play important roles in the pathogenesis of DM.https://doi.org/10.1002/rai2.12078dermatomyositisinnate immuneISG15lncRNARNA‐sequencingtransporter associated with antigen processing 1 (TAP1)
spellingShingle Ke Li
Yubao Ma
Shanchun Zhang
Rui Ban
Qiang Shi
High‐throughput transcriptomic profiling of mRNAs and lncRNAs in the dermatomyositis muscle by RNA sequencing
Rheumatology & Autoimmunity
dermatomyositis
innate immune
ISG15
lncRNA
RNA‐sequencing
transporter associated with antigen processing 1 (TAP1)
title High‐throughput transcriptomic profiling of mRNAs and lncRNAs in the dermatomyositis muscle by RNA sequencing
title_full High‐throughput transcriptomic profiling of mRNAs and lncRNAs in the dermatomyositis muscle by RNA sequencing
title_fullStr High‐throughput transcriptomic profiling of mRNAs and lncRNAs in the dermatomyositis muscle by RNA sequencing
title_full_unstemmed High‐throughput transcriptomic profiling of mRNAs and lncRNAs in the dermatomyositis muscle by RNA sequencing
title_short High‐throughput transcriptomic profiling of mRNAs and lncRNAs in the dermatomyositis muscle by RNA sequencing
title_sort high throughput transcriptomic profiling of mrnas and lncrnas in the dermatomyositis muscle by rna sequencing
topic dermatomyositis
innate immune
ISG15
lncRNA
RNA‐sequencing
transporter associated with antigen processing 1 (TAP1)
url https://doi.org/10.1002/rai2.12078
work_keys_str_mv AT keli highthroughputtranscriptomicprofilingofmrnasandlncrnasinthedermatomyositismusclebyrnasequencing
AT yubaoma highthroughputtranscriptomicprofilingofmrnasandlncrnasinthedermatomyositismusclebyrnasequencing
AT shanchunzhang highthroughputtranscriptomicprofilingofmrnasandlncrnasinthedermatomyositismusclebyrnasequencing
AT ruiban highthroughputtranscriptomicprofilingofmrnasandlncrnasinthedermatomyositismusclebyrnasequencing
AT qiangshi highthroughputtranscriptomicprofilingofmrnasandlncrnasinthedermatomyositismusclebyrnasequencing